This is a Validated Antibody Database (VAD) review about human androgen receptor, based on 110 published articles (read how Labome selects the articles), using androgen receptor antibody in all methods. It is aimed to help Labome visitors find the most suited androgen receptor antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
androgen receptor synonym: AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM

Knockout validation
Abcam
domestic rabbit monoclonal (EPR1535(2))
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 1e
  • immunohistochemistry; mouse; 1:200; loading ...; fig 1h
Abcam androgen receptor antibody (Abcam, ab133273) was used in western blot knockout validation on mouse samples at 1:1000 (fig 1e) and in immunohistochemistry on mouse samples at 1:200 (fig 1h). Sci Rep (2021) ncbi
Abcam
domestic rabbit monoclonal (EP670Y)
  • immunohistochemistry knockout validation; mouse; fig 2
Abcam androgen receptor antibody (Abcam, ab52615) was used in immunohistochemistry knockout validation on mouse samples (fig 2). Horm Behav (2014) ncbi
Abcam
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 4c
Abcam androgen receptor antibody (Abcam, ab74272) was used in western blot on human samples at 1:2000 (fig 4c). Nat Commun (2021) ncbi
domestic rabbit monoclonal (EPR15656-290)
  • western blot; mouse; loading ...; fig 5b
Abcam androgen receptor antibody (Abcam, ab273500) was used in western blot on mouse samples (fig 5b). Antioxidants (Basel) (2021) ncbi
domestic rabbit monoclonal (EPR1535(2))
  • immunohistochemistry; rat; loading ...; fig 3
  • western blot; rat; 1:1000; loading ...; fig 2
Abcam androgen receptor antibody (Abcam, 133273) was used in immunohistochemistry on rat samples (fig 3) and in western blot on rat samples at 1:1000 (fig 2). J Mol Med (Berl) (2021) ncbi
domestic rabbit monoclonal (ER179(2))
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig s1f
Abcam androgen receptor antibody (Abcam, ab108341) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s1f). Nat Commun (2021) ncbi
domestic rabbit monoclonal (EPR1535(2))
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 1f
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 2d, 3a
Abcam androgen receptor antibody (Abcam, ab133273) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1f) and in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2d, 3a). Cell Prolif (2021) ncbi
domestic rabbit monoclonal (EPR1535(2))
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 1e
  • immunohistochemistry; mouse; 1:200; loading ...; fig 1h
Abcam androgen receptor antibody (Abcam, ab133273) was used in western blot knockout validation on mouse samples at 1:1000 (fig 1e) and in immunohistochemistry on mouse samples at 1:200 (fig 1h). Sci Rep (2021) ncbi
domestic rabbit monoclonal (ER179(2))
  • western blot; human; loading ...; fig 1c, 1d, 4d
Abcam androgen receptor antibody (Abcam, ab108341) was used in western blot on human samples (fig 1c, 1d, 4d). Cancer Sci (2020) ncbi
domestic rabbit polyclonal
  • chromatin immunoprecipitation; human; ; loading ...; fig 1j
Abcam androgen receptor antibody (Abcam, ab74272) was used in chromatin immunoprecipitation on human samples at (fig 1j). elife (2019) ncbi
domestic rabbit monoclonal (ER179(2))
  • western blot; mouse; 1:1000; loading ...; fig 2b
Abcam androgen receptor antibody (Abcam, ab108341) was used in western blot on mouse samples at 1:1000 (fig 2b). Mol Cancer Ther (2019) ncbi
domestic rabbit monoclonal (ER179(2))
  • western blot; human; 1:1000; loading ...; fig ex3c
  • ChIP-Seq; mouse; 1:1000; loading ...; fig ex5a
Abcam androgen receptor antibody (Abcam, ER179(2)) was used in western blot on human samples at 1:1000 (fig ex3c) and in ChIP-Seq on mouse samples at 1:1000 (fig ex5a). Nature (2019) ncbi
domestic rabbit monoclonal (ER179(2))
  • immunoprecipitation; human; loading ...; fig 3d
  • western blot; human; 1:1000; loading ...; fig 1e, 1s1c
Abcam androgen receptor antibody (Abcam, ab108341) was used in immunoprecipitation on human samples (fig 3d) and in western blot on human samples at 1:1000 (fig 1e, 1s1c). elife (2019) ncbi
domestic rabbit monoclonal (EPR15656)
  • western blot; human; fig 1a
Abcam androgen receptor antibody (Abcam, ab198394) was used in western blot on human samples (fig 1a). Proc Natl Acad Sci U S A (2018) ncbi
domestic rabbit monoclonal (EP670Y)
  • other; human; loading ...; fig 4c
Abcam androgen receptor antibody (Abcam, ab52615) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (ER179(2))
  • chromatin immunoprecipitation; human; loading ...; fig 4a
Abcam androgen receptor antibody (abcam, ab108341) was used in chromatin immunoprecipitation on human samples (fig 4a). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig S3a
Abcam androgen receptor antibody (Abcam, ab74272) was used in western blot on human samples (fig S3a). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • chromatin immunoprecipitation; rat; loading ...; tbl 1
In order to examine the presence of a functional estrogen response element upstream of Arpc1b and Evl genes and androgen response element upstream of Picalm, Eea1, and Stx5a genes, Abcam androgen receptor antibody (Abcam, 74272) was used in chromatin immunoprecipitation on rat samples (tbl 1). J Steroid Biochem Mol Biol (2017) ncbi
domestic rabbit monoclonal (EPR1535(2))
  • immunohistochemistry - paraffin section; rat; loading ...; fig 5a
In order to ask if topical dehydroepiandrosterone ameliorates Meibomian gland dysfunction caused by isotretinoin, Abcam androgen receptor antibody (Abcam, ab133273) was used in immunohistochemistry - paraffin section on rat samples (fig 5a). Ann Anat (2017) ncbi
domestic rabbit monoclonal (EPR1535(2))
  • immunohistochemistry; mouse; 1:1000; fig 7b
  • western blot; mouse; 1:1000; loading ...; fig 4b
Abcam androgen receptor antibody (Epitomics, ab133273) was used in immunohistochemistry on mouse samples at 1:1000 (fig 7b) and in western blot on mouse samples at 1:1000 (fig 4b). J Comp Neurol (2017) ncbi
domestic rabbit monoclonal (EPR1535(2))
  • immunohistochemistry - paraffin section; mouse; fig 3
  • western blot; mouse; fig 1
Abcam androgen receptor antibody (Abcam, ab133273) was used in immunohistochemistry - paraffin section on mouse samples (fig 3) and in western blot on mouse samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EPR1535(2))
  • western blot; human; 1:1000; loading ...; fig 2b
In order to propose that the NKX3.1-G9a-UTY transcriptional regulatory network is essential for prostate differentiation, Abcam androgen receptor antibody (Abcam, ab133273) was used in western blot on human samples at 1:1000 (fig 2b). Science (2016) ncbi
domestic rabbit monoclonal (EPR1535(2))
  • western blot; human; loading ...; fig 5b
Abcam androgen receptor antibody (Abcam, ab133273) was used in western blot on human samples (fig 5b). Oncotarget (2016) ncbi
mouse monoclonal (AR 441)
  • immunohistochemistry; human; loading ...; fig 5
Abcam androgen receptor antibody (Abcam, ab9474) was used in immunohistochemistry on human samples (fig 5). Int J Oncol (2016) ncbi
domestic rabbit monoclonal (EPR1535(2))
  • immunohistochemistry; human; 1:100; fig s1c
Abcam androgen receptor antibody (Abcam, ab133273) was used in immunohistochemistry on human samples at 1:100 (fig s1c). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; fig 4
In order to assess mediation by androgen control of autoimmune regulator due to sex bias in CNS autoimmune disease, Abcam androgen receptor antibody (Abcam, Ab74272) was used in immunocytochemistry on mouse samples (fig 4). Nat Commun (2016) ncbi
domestic rabbit monoclonal (EPR1535(2))
  • immunohistochemistry - paraffin section; dogs; 1:200; loading ...; fig 3c
  • western blot; dogs; 1:1000; loading ...; fig 3b
  • western blot; human; 1:1000; loading ...; fig 3b
In order to study canine prostate cancer cell line CHP-1 and co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein, Abcam androgen receptor antibody (Abcam, EPR1535) was used in immunohistochemistry - paraffin section on dogs samples at 1:200 (fig 3c), in western blot on dogs samples at 1:1000 (fig 3b) and in western blot on human samples at 1:1000 (fig 3b). Vet Comp Oncol (2017) ncbi
domestic rabbit monoclonal (EPR1535(2))
  • immunohistochemistry - paraffin section; human; 1:100; loading ...
Abcam androgen receptor antibody (Abcam, ab133273) was used in immunohistochemistry - paraffin section on human samples at 1:100. Oncotarget (2015) ncbi
mouse monoclonal (AR 441)
  • immunohistochemistry - paraffin section; mouse; fig s3
  • immunohistochemistry - paraffin section; human; fig 1
In order to study induction of sarcomatoid phenotype solely due to ductal activation of oncogenic KRAS, Abcam androgen receptor antibody (Abcam, ab9474) was used in immunohistochemistry - paraffin section on mouse samples (fig s3) and in immunohistochemistry - paraffin section on human samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (AR 441)
  • western blot; human; 1:1000
Abcam androgen receptor antibody (Abcam, Ab9474) was used in western blot on human samples at 1:1000. Scand J Med Sci Sports (2016) ncbi
domestic rabbit monoclonal (EPR1535(2))
  • immunohistochemistry - paraffin section; mouse
In order to study the pathogenesis of prostate cance, Abcam androgen receptor antibody (Abcam, ab133273) was used in immunohistochemistry - paraffin section on mouse samples . Prostate (2014) ncbi
domestic rabbit monoclonal (EP670Y)
  • immunohistochemistry knockout validation; mouse; fig 2
Abcam androgen receptor antibody (Abcam, ab52615) was used in immunohistochemistry knockout validation on mouse samples (fig 2). Horm Behav (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (441)
  • western blot; human; 1:2000; fig 4a
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, Sc?\7305) was used in western blot on human samples at 1:2000 (fig 4a). Cancers (Basel) (2021) ncbi
mouse monoclonal (441)
  • immunohistochemistry - frozen section; human; loading ...; fig 5e
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc-7305) was used in immunohistochemistry - frozen section on human samples (fig 5e). Acta Neuropathol Commun (2019) ncbi
mouse monoclonal (441)
  • immunoprecipitation; human; loading ...; fig 2a
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz Biotechnology Inc, sc-7305) was used in immunoprecipitation on human samples (fig 2a). Oncogene (2018) ncbi
mouse monoclonal (441)
  • flow cytometry; human; loading ...; fig 2c
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc-7305) was used in flow cytometry on human samples (fig 2c). Mol Cancer Res (2017) ncbi
mouse monoclonal (441)
  • immunohistochemistry; human; 1:800; fig 1a
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc-7305) was used in immunohistochemistry on human samples at 1:800 (fig 1a). J Cell Sci (2017) ncbi
mouse monoclonal (441)
  • western blot; human; loading ...; fig e10b
In order to research the effect of polyglutamine tracts on the autophagy process, Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc-7305) was used in western blot on human samples (fig e10b). Nature (2017) ncbi
mouse monoclonal
  • immunoprecipitation; human; loading ...; fig 3d
In order to search for signaling pathways that modulate polyglutamine-androgen receptor phosphorylation for therapy development, Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, 441) was used in immunoprecipitation on human samples (fig 3d). Sci Transl Med (2016) ncbi
mouse monoclonal (441)
  • western blot; mouse; loading ...; fig s4
  • western blot; rat; loading ...; fig 3g
  • immunoprecipitation; human
  • western blot; human; loading ...; fig 1a
In order to search for signaling pathways that modulate polyglutamine-androgen receptor phosphorylation for therapy development, Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc-7305) was used in western blot on mouse samples (fig s4), in western blot on rat samples (fig 3g), in immunoprecipitation on human samples and in western blot on human samples (fig 1a). Sci Transl Med (2016) ncbi
mouse monoclonal (441)
  • western blot; African green monkey; loading ...; fig 4c
In order to explore acetylation of arrest-defective protein 1 in prostate cancer cells, Santa Cruz Biotechnology androgen receptor antibody (santa cruz, sc-7305) was used in western blot on African green monkey samples (fig 4c). Oncotarget (2016) ncbi
mouse monoclonal (441)
  • immunocytochemistry; human; 1:500; loading ...; fig 4d
  • western blot; human; loading ...; fig 4a
In order to describe the crosstalk of alphavbeta6-integrin and androgen receptor in prostate cancer., Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, 441) was used in immunocytochemistry on human samples at 1:500 (fig 4d) and in western blot on human samples (fig 4a). Cancer Res (2016) ncbi
mouse monoclonal
  • immunocytochemistry; human; 1:500; loading ...; fig 4d
  • western blot; human; loading ...; fig 4a
In order to describe the crosstalk of alphavbeta6-integrin and androgen receptor in prostate cancer., Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, 441) was used in immunocytochemistry on human samples at 1:500 (fig 4d) and in western blot on human samples (fig 4a). Cancer Res (2016) ncbi
mouse monoclonal (441)
  • immunoprecipitation; rat; fig 3b
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc-7305) was used in immunoprecipitation on rat samples (fig 3b). Sci Rep (2016) ncbi
mouse monoclonal (441)
  • western blot; human; fig 3
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc-7305) was used in western blot on human samples (fig 3). Nat Commun (2016) ncbi
mouse monoclonal (441)
  • western blot; human; fig 1
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc-7305) was used in western blot on human samples (fig 1). elife (2016) ncbi
mouse monoclonal (441)
  • immunoprecipitation; human; loading ...; fig 1c
  • immunocytochemistry; human; 1:400; loading ...; fig 1a
Santa Cruz Biotechnology androgen receptor antibody (Santa-Cruz, sc-7305) was used in immunoprecipitation on human samples (fig 1c) and in immunocytochemistry on human samples at 1:400 (fig 1a). Oncotarget (2016) ncbi
mouse monoclonal (441)
  • immunohistochemistry - paraffin section; mouse; 1:30; fig 2
In order to study an increase in susceptibility of mice bladder cancer by conditional expression of the androgen receptor, Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz Biotechnology, sc-7305) was used in immunohistochemistry - paraffin section on mouse samples at 1:30 (fig 2). PLoS ONE (2016) ncbi
mouse monoclonal (441)
  • immunoprecipitation; human; fig 8
  • immunocytochemistry; human
  • western blot; human; fig 5
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc-7305) was used in immunoprecipitation on human samples (fig 8), in immunocytochemistry on human samples and in western blot on human samples (fig 5). Genes Cancer (2015) ncbi
mouse monoclonal (441)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
  • western blot; human; fig 1
In order to test if osteoblasts regulate the intratumoral steroidogenesis of castration-resistant prostate cancer, Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc7305) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2) and in western blot on human samples (fig 1). Mol Cell Endocrinol (2016) ncbi
mouse monoclonal (441)
  • immunohistochemistry - paraffin section; mouse; fig 3
  • immunohistochemistry - paraffin section; human; fig 7
  • chromatin immunoprecipitation; human; fig 4
  • immunoprecipitation; human; fig 2
  • western blot; human; fig 2
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz Biotechnology, sc-7305) was used in immunohistochemistry - paraffin section on mouse samples (fig 3), in immunohistochemistry - paraffin section on human samples (fig 7), in chromatin immunoprecipitation on human samples (fig 4), in immunoprecipitation on human samples (fig 2) and in western blot on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (441)
  • immunocytochemistry; human; fig 2a
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc-7305) was used in immunocytochemistry on human samples (fig 2a). Oncotarget (2015) ncbi
mouse monoclonal (441)
  • immunoprecipitation; human; fig 1
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz Biotechnology, sc-7305) was used in immunoprecipitation on human samples (fig 1). J Biol Chem (2015) ncbi
mouse monoclonal (441)
  • immunoprecipitation; human; fig s3
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc-7305) was used in immunoprecipitation on human samples (fig s3). Carcinogenesis (2015) ncbi
mouse monoclonal (441)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
  • western blot; human; 1:500; fig 1
In order to elucidate role of androgen signaling in beta-catenin-initiated prostate tumorigenesis, Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc-7305) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1) and in western blot on human samples at 1:500 (fig 1). Oncogene (2016) ncbi
mouse monoclonal (441)
  • western blot; human; fig 5
Santa Cruz Biotechnology androgen receptor antibody (Santa-Cruz, sc-7305) was used in western blot on human samples (fig 5). Nucleic Acids Res (2015) ncbi
mouse monoclonal (441)
  • immunocytochemistry; human
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz Biotechnology, sc-7305) was used in immunocytochemistry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (441)
  • chromatin immunoprecipitation; human
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz Biotechnology, sc-7305) was used in chromatin immunoprecipitation on human samples . BMC Cancer (2014) ncbi
mouse monoclonal (441)
  • western blot; human
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz, sc-7305) was used in western blot on human samples . Nucleic Acids Res (2014) ncbi
mouse monoclonal (441)
  • western blot; human; fig 3
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz Biotechnology, sc-7305) was used in western blot on human samples (fig 3). Genes Dev (2013) ncbi
mouse monoclonal (441)
  • western blot; human
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz Biotechnology, sc-7305) was used in western blot on human samples . Oncogene (2014) ncbi
mouse monoclonal (441)
  • western blot; human
Santa Cruz Biotechnology androgen receptor antibody (Santa Cruz Biotechnology, sc-7305) was used in western blot on human samples . Am J Physiol Endocrinol Metab (2011) ncbi
Invitrogen
mouse monoclonal (AR 441)
  • western blot; mouse; 1:1000; fig 5c
Invitrogen androgen receptor antibody (Invitrogen, MA5-13426) was used in western blot on mouse samples at 1:1000 (fig 5c). Mol Ther Nucleic Acids (2021) ncbi
mouse monoclonal (AR 441)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3b
In order to report how hormonal changes affect striae distensae pathogenesis, Invitrogen androgen receptor antibody (Thermo Fisher Scientific, Ab-1) was used in immunohistochemistry - paraffin section on human samples (fig 3b). J Cosmet Dermatol (2017) ncbi
rat monoclonal (AN1-15)
  • immunohistochemistry - paraffin section; rat; loading ...; fig 2a
In order to study the protective role of green tea extract on cadmium chloride-induced reproductive toxicities in rats, Invitrogen androgen receptor antibody (Thermo Fisher, MA1-150) was used in immunohistochemistry - paraffin section on rat samples (fig 2a). Reprod Biol (2016) ncbi
mouse monoclonal (AR 441)
  • western blot; human; 1:400; loading ...; fig 3b
In order to test if the androgen receptor modulates peroxisome proliferator activated receptor gamma expression and function within human prostate cancer cells, Invitrogen androgen receptor antibody (Lab Vision Corporation, AR 441) was used in western blot on human samples at 1:400 (fig 3b). J Cell Physiol (2016) ncbi
domestic rabbit polyclonal
In order to test if testosterone can have a direct effect on dopamine neurons, Invitrogen androgen receptor antibody (Affinity BioReagents, PA1-110) was used . Schizophr Res (2015) ncbi
mouse monoclonal (AR 441)
  • western blot; human
Invitrogen androgen receptor antibody (NeoMarkers-Lab Vision Corporation, AR441) was used in western blot on human samples . Oncotarget (2015) ncbi
mouse monoclonal (AR 441)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen androgen receptor antibody (LabVision, AR441) was used in immunohistochemistry - paraffin section on human samples at 1:100. Int J Oncol (2014) ncbi
mouse monoclonal (H7507)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen androgen receptor antibody (Invitrogen, H7507) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (AR 441)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunohistochemistry; human; 1:100
In order to report on three cases of polymorphous adenocarcinoma of the breast, Invitrogen androgen receptor antibody (Neomarkers, AR 441) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunohistochemistry on human samples at 1:100. Virchows Arch (2006) ncbi
Active Motif
domestic rabbit polyclonal
  • chromatin immunoprecipitation; human; fig 5
Active Motif androgen receptor antibody (Active Motif, 39781) was used in chromatin immunoprecipitation on human samples (fig 5). Mol Endocrinol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3b
Active Motif androgen receptor antibody (Active Motif, 39781) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D6F11)
  • ChIP-Seq; human; loading ...; fig 5h
  • immunohistochemistry - paraffin section; human; loading ...; fig 4g
  • western blot; human; 1:2000; loading ...; fig 6h
Cell Signaling Technology androgen receptor antibody (CST, 5153) was used in ChIP-Seq on human samples (fig 5h), in immunohistochemistry - paraffin section on human samples (fig 4g) and in western blot on human samples at 1:2000 (fig 6h). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D6F11)
  • ChIP-Seq; human; loading ...; fig 5d
Cell Signaling Technology androgen receptor antibody (Cell Signaling, 5153T) was used in ChIP-Seq on human samples (fig 5d). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (D6F11)
  • western blot; human; 1:1000; loading ...; fig 2a
Cell Signaling Technology androgen receptor antibody (Cell Signaling Technology, D6F11) was used in western blot on human samples at 1:1000 (fig 2a). Mol Ther Nucleic Acids (2021) ncbi
domestic rabbit monoclonal (D6F11)
  • mass cytometry; human; loading ...; fig 3a
Cell Signaling Technology androgen receptor antibody (Cell Signaling Technologies, 5153) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
domestic rabbit monoclonal (D6F11)
  • western blot; human; loading ...; fig s2a
Cell Signaling Technology androgen receptor antibody (Cell Signaling, 5153) was used in western blot on human samples (fig s2a). Theranostics (2018) ncbi
domestic rabbit monoclonal (D6F11)
  • western blot; human; loading ...; fig 4j
In order to study the role of ACK1/TNK2 in histone H4 Tyr88-phosphorylation and androgen receptor expression in prostate cancer, Cell Signaling Technology androgen receptor antibody (Cell Signaling, 5153) was used in western blot on human samples (fig 4j). Cancer Cell (2017) ncbi
domestic rabbit monoclonal (D6F11)
  • immunohistochemistry - paraffin section; human; 1:400; loading ...; fig 6a
  • western blot; human; 1:2000; loading ...; fig 5b
In order to suggest that miR-24 is a central regulator of race-related prostate cancer, Cell Signaling Technology androgen receptor antibody (Cell Signaling, 5153) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 6a) and in western blot on human samples at 1:2000 (fig 5b). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D6F11)
  • western blot; human; loading ...; fig 2g
Cell Signaling Technology androgen receptor antibody (Cell Signaling, D6F11) was used in western blot on human samples (fig 2g). Oncogene (2017) ncbi
domestic rabbit monoclonal (D6F11)
  • western blot; human; fig 2a
In order to identify pathways that contribute to resistance to the antiandrogen drug enzalutamide, Cell Signaling Technology androgen receptor antibody (CST, 5153) was used in western blot on human samples (fig 2a). Science (2017) ncbi
domestic rabbit monoclonal (D6F11)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5a
  • western blot; human; loading ...; fig 4b
In order to demonstrate that differential expression of miR-34b and AR are associated with prostate cancer aggressiveness in African-Americans, Cell Signaling Technology androgen receptor antibody (Cell signaling, 5153) was used in immunohistochemistry - paraffin section on human samples (fig 5a) and in western blot on human samples (fig 4b). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D6F11)
  • western blot; human; fig 1
Cell Signaling Technology androgen receptor antibody (Cell signaling, 5153) was used in western blot on human samples (fig 1). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D6F11)
  • western blot; human; 1:2000; loading ...; fig 1d
Cell Signaling Technology androgen receptor antibody (Cell signaling, D6F11) was used in western blot on human samples at 1:2000 (fig 1d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D6F11)
  • immunohistochemistry; human; fig s3
Cell Signaling Technology androgen receptor antibody (Cell Signaling, 5153) was used in immunohistochemistry on human samples (fig s3). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D6F11)
  • western blot; human; 1:2000; loading ...; fig 5f
In order to identify genetic features regulating cell survival after exposure to radiation., Cell Signaling Technology androgen receptor antibody (Cell Signalling, 5153) was used in western blot on human samples at 1:2000 (fig 5f). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D6F11)
  • immunohistochemistry; human; 1:200; fig e9
In order to study triple-negative breast cancer and BET bromodomain inhibitor response and resistance, Cell Signaling Technology androgen receptor antibody (Cell Signaling, 5153S) was used in immunohistochemistry on human samples at 1:200 (fig e9). Nature (2016) ncbi
domestic rabbit polyclonal
  • immunoprecipitation; human; fig 8
  • western blot; human; fig 7
In order to characterize modulation of microtubular structure and HSP90alpha chaperone activity against prostate cancer by 4-hydroxybenzoic acid derivatives as HDAC6-specific inhibitors, Cell Signaling Technology androgen receptor antibody (Cell signaling, 3202) was used in immunoprecipitation on human samples (fig 8) and in western blot on human samples (fig 7). Biochem Pharmacol (2016) ncbi
domestic rabbit monoclonal (D6F11)
  • western blot; human; fig s11
Cell Signaling Technology androgen receptor antibody (Cell Signaling, D6F11) was used in western blot on human samples (fig s11). Nat Genet (2015) ncbi
domestic rabbit monoclonal (D6F11)
  • western blot; human; fig 3
Cell Signaling Technology androgen receptor antibody (Cell Signaling Technology, 5153) was used in western blot on human samples (fig 3). Am J Transl Res (2015) ncbi
Dako
mouse monoclonal (AR441)
  • immunohistochemistry - paraffin section; human; 1:100; fig 7i
Dako androgen receptor antibody (Dako, M3562) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 7i). Nat Commun (2021) ncbi
mouse monoclonal (AR441)
  • immunohistochemistry; human; 1:40; loading ...
Dako androgen receptor antibody (Dako, AR441) was used in immunohistochemistry on human samples at 1:40. Mod Pathol (2020) ncbi
mouse monoclonal (AR441)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; tbl 2
Dako androgen receptor antibody (Dako, AR 441) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 2). Cureus (2020) ncbi
mouse monoclonal (AR441)
  • immunohistochemistry; mouse; loading ...; fig 4c
Dako androgen receptor antibody (DAKO, M3562) was used in immunohistochemistry on mouse samples (fig 4c). Cell Rep (2018) ncbi
mouse monoclonal (AR441)
  • immunohistochemistry - frozen section; human; 1:400; fig 1e
Dako androgen receptor antibody (Dako, AR441) was used in immunohistochemistry - frozen section on human samples at 1:400 (fig 1e). Int J Mol Sci (2017) ncbi
mouse monoclonal (AR441)
  • immunohistochemistry - paraffin section; human; 1:10; loading ...; fig 1
Dako androgen receptor antibody (Dako, AR441) was used in immunohistochemistry - paraffin section on human samples at 1:10 (fig 1). Taiwan J Obstet Gynecol (2016) ncbi
mouse monoclonal (AR441)
  • immunohistochemistry - paraffin section; human; 1:500; fig 3
Dako androgen receptor antibody (Dako, AR441) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 3). Nat Genet (2015) ncbi
mouse monoclonal (AR441)
  • immunohistochemistry; human; 1:100
Dako androgen receptor antibody (Dako, M3562) was used in immunohistochemistry on human samples at 1:100. Hum Pathol (2015) ncbi
mouse monoclonal (AR441)
  • immunohistochemistry - paraffin section; human; 1:400
Dako androgen receptor antibody (DAKO, M3562) was used in immunohistochemistry - paraffin section on human samples at 1:400. J Clin Endocrinol Metab (2015) ncbi
mouse monoclonal (AR441)
  • immunohistochemistry - paraffin section; human
In order to characterize two cases of primary thymic adenocarcinoma with enteric differentiation, Dako androgen receptor antibody (Dako, M3562) was used in immunohistochemistry - paraffin section on human samples . Am J Surg Pathol (2015) ncbi
mouse monoclonal (AR441)
  • immunohistochemistry; human; 1:50
Dako androgen receptor antibody (DAKO, AR441) was used in immunohistochemistry on human samples at 1:50. Mol Cell Endocrinol (2015) ncbi
mouse monoclonal (AR441)
  • western blot; mouse; loading ...; fig 1b
  • western blot; human; 1:1000; loading ...; fig 1a
Dako androgen receptor antibody (Dako, AR441) was used in western blot on mouse samples (fig 1b) and in western blot on human samples at 1:1000 (fig 1a). Mol Oncol (2015) ncbi
mouse monoclonal (AR441)
  • immunohistochemistry; human
In order to describe the histological features canalicular adenoma, Dako androgen receptor antibody (Dako, AR441) was used in immunohistochemistry on human samples . Head Neck Pathol (2015) ncbi
mouse monoclonal (AR441)
  • immunohistochemistry; human
In order to study salivary duct carcinoma with rhabdoid features, Dako androgen receptor antibody (DakoCytomation, AR441) was used in immunohistochemistry on human samples . Head Neck (2014) ncbi
mouse monoclonal (AR441)
  • western blot; human; 1:500; fig 1
Dako androgen receptor antibody (Dako, M3562) was used in western blot on human samples at 1:500 (fig 1). PLoS ONE (2012) ncbi
BD Biosciences
mouse monoclonal (G122-77)
  • western blot; human; 1:10,000; loading ...; fig 6s1a
BD Biosciences androgen receptor antibody (BD Bioscience, 554226) was used in western blot on human samples at 1:10,000 (fig 6s1a). elife (2019) ncbi
mouse monoclonal (G122-25)
  • immunohistochemistry - paraffin section; domestic rabbit; 1:100
  • immunohistochemistry; domestic rabbit; fig 18
In order to outline the protocols for antibodies used for immunohistochemical studies, BD Biosciences androgen receptor antibody (BD Biosciences, 554224) was used in immunohistochemistry - paraffin section on domestic rabbit samples at 1:100 and in immunohistochemistry on domestic rabbit samples (fig 18). J Toxicol Pathol (2017) ncbi
mouse monoclonal (G122-77)
  • western blot; human; fig 3
BD Biosciences androgen receptor antibody (BD Bioscience, 554226) was used in western blot on human samples (fig 3). Oncoscience (2015) ncbi
mouse monoclonal (G122-434)
  • immunocytochemistry; human
BD Biosciences androgen receptor antibody (BD Biosciences, 554225) was used in immunocytochemistry on human samples . Br J Cancer (2015) ncbi
mouse monoclonal (G122-77)
  • western blot; human
BD Biosciences androgen receptor antibody (BD, G122-77) was used in western blot on human samples . PLoS ONE (2012) ncbi
Leica Biosystems
mouse monoclonal (AR27)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to classify triple-negative breast cancer into subtypes, Leica Biosystems androgen receptor antibody (Novocastra, NCL-AR-318) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Oncol Lett (2016) ncbi
mouse monoclonal (AR27)
  • immunohistochemistry; human; 1:50
In order to study aromatase inhibitor therapy in breast cancer, Leica Biosystems androgen receptor antibody (Novacastra, 318-CE) was used in immunohistochemistry on human samples at 1:50. Clin Cancer Res (2016) ncbi
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1a
Leica Biosystems androgen receptor antibody (Novocastra, NCL-AR-2F12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1a). Asian J Androl (2015) ncbi
mouse monoclonal (AR27)
  • immunohistochemistry - paraffin section; human; 1:100
Leica Biosystems androgen receptor antibody (Novocatra Laboratories, AR27) was used in immunohistochemistry - paraffin section on human samples at 1:100. Malays J Pathol (2014) ncbi
MilliporeSigma
domestic rabbit monoclonal (SP242)
  • immunohistochemistry; human; fig s5d
MilliporeSigma androgen receptor antibody (Sigma, SP242) was used in immunohistochemistry on human samples (fig s5d). Nat Commun (2021) ncbi
Articles Reviewed
  1. Gupta A, Mandal K, Singh P, Sarkar R, Majumdar S. Declining levels of miR-382-3p at puberty trigger the onset of spermatogenesis. Mol Ther Nucleic Acids. 2021;26:192-207 pubmed publisher
  2. Goel S, Bhatia V, Kundu S, Biswas T, Carskadon S, Gupta N, et al. Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression. Nat Commun. 2021;12:5325 pubmed publisher
  3. Kalogirou C, Linxweiler J, Schmucker P, Snaebjornsson M, Schmitz W, Wach S, et al. MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer. Nat Commun. 2021;12:5066 pubmed publisher
  4. Risbridger G, Clark A, Porter L, Toivanen R, Bakshi A, Lister N, et al. The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology. Nat Commun. 2021;12:5049 pubmed publisher
  5. Lei H, Wang Z, Jiang D, Liu F, Liu M, Lei X, et al. CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer. Cell Death Dis. 2021;12:740 pubmed publisher
  6. Leach D, Mohr A, Giotis E, Cil E, Isac A, Yates L, et al. The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells. Nat Commun. 2021;12:4068 pubmed publisher
  7. Fan H, Wang S, Wang H, Sun M, Wu S, Bao W. Melatonin Ameliorates the Toxicity Induced by Deoxynivalenol in Murine Ovary Granulosa Cells by Antioxidative and Anti-Inflammatory Effects. Antioxidants (Basel). 2021;10: pubmed publisher
  8. Zhang Y, Hu M, Yang F, Zhang Y, Ma S, Zhang D, et al. Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance. J Mol Med (Berl). 2021;99:1427-1446 pubmed publisher
  9. Brady N, Bagadion A, Singh R, Conteduca V, Van Emmenis L, Arceci E, et al. Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer. Nat Commun. 2021;12:3372 pubmed publisher
  10. Liu K, Jing N, Wang D, Xu P, Wang J, Chen X, et al. A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour-immune cell communication. Cell Prolif. 2021;54:e13056 pubmed publisher
  11. Tomas D, McLeod V, Chiam M, Wanniarachchillage N, Boon W, Turner B. Dissociation of disease onset, progression and sex differences from androgen receptor levels in a mouse model of amyotrophic lateral sclerosis. Sci Rep. 2021;11:9255 pubmed publisher
  12. Zhang X, Huang Z, Wang J, Ma Z, Yang J, Corey E, et al. Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling. Cancers (Basel). 2021;13: pubmed publisher
  13. Corbin J, Georgescu C, Wren J, Xu C, Asch A, Ruiz Echevarría M. Seed-mediated RNA interference of androgen signaling and survival networks induces cell death in prostate cancer cells. Mol Ther Nucleic Acids. 2021;24:337-351 pubmed publisher
  14. Christgen M, Bartels S, van Luttikhuizen J, Bublitz J, Rieger L, Christgen H, et al. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements. Mod Pathol. 2020;33:2483-2498 pubmed publisher
  15. Mumtaz S, Hussain Z, Janjua T, Hashmi A, Qureshi S, Tariq M, et al. Androgen Receptor: Evaluation and Correlation with Recurrence and Clinicopathological Parameters in Papillary Urothelial Carcinomas of the Urinary Bladder. Cureus. 2020;12:e6715 pubmed publisher
  16. Zhao J, Zhang Y, Liu X, Zhu F, Xie F, Jiang C, et al. RNA-binding protein Musashi2 stabilizing androgen receptor drives prostate cancer progression. Cancer Sci. 2020;111:369-382 pubmed publisher
  17. Lenting K, van den Heuvel C, van Ewijk A, Elmelik D, de Boer R, Tindall E, et al. Mapping actionable pathways and mutations in brain tumours using targeted RNA next generation sequencing. Acta Neuropathol Commun. 2019;7:185 pubmed publisher
  18. Munkley J, Li L, Krishnan S, Hysenaj G, Scott E, Dalgliesh C, et al. Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer. elife. 2019;8: pubmed publisher
  19. Mao N, Gao D, Hu W, Hieronymus H, Wang S, Lee Y, et al. Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes. Mol Cancer Ther. 2019;18:1577-1586 pubmed publisher
  20. Adams E, Karthaus W, Hoover E, Liu D, Gruet A, Zhang Z, et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 2019;571:408-412 pubmed publisher
  21. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  22. Lee E, Wongvipat J, Choi D, Wang P, Lee Y, Zheng D, et al. GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance. elife. 2019;8: pubmed publisher
  23. Barros Silva J, Linn D, Steiner I, Guo G, Ali A, Pakula H, et al. Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer. Cell Rep. 2018;25:3504-3518.e6 pubmed publisher
  24. Fan L, Zhang F, Xu S, Cui X, Hussain A, Fazli L, et al. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells. Proc Natl Acad Sci U S A. 2018;115:E4584-E4593 pubmed publisher
  25. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  26. Li N, Truong S, Nouri M, Moore J, Al Nakouzi N, Lubik A, et al. Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3. Oncogene. 2018;37:2313-2325 pubmed publisher
  27. Zeng J, Liu W, Fan Y, He D, Li L. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy. Theranostics. 2018;8:109-123 pubmed publisher
  28. Shukla S, Cyrta J, Murphy D, Walczak E, Ran L, Agrawal P, et al. Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance. Cancer Cell. 2017;32:792-806.e7 pubmed publisher
  29. Mahajan K, Malla P, Lawrence H, Chen Z, Kumar Sinha C, Malik R, et al. ACK1/TNK2 Regulates Histone H4 Tyr88-phosphorylation and AR Gene Expression in Castration-Resistant Prostate Cancer. Cancer Cell. 2017;31:790-803.e8 pubmed publisher
  30. Kristiansen I, Stephan C, Jung K, Dietel M, Rieger A, Tolkach Y, et al. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA. Int J Mol Sci. 2017;18: pubmed publisher
  31. White M, Lin C, Rajapakshe K, Dong J, Shi Y, Tsouko E, et al. Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer. Mol Cancer Res. 2017;15:1017-1028 pubmed publisher
  32. Frank S, Berger P, Ljungman M, Miranti C. Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC. J Cell Sci. 2017;130:1952-1964 pubmed publisher
  33. Ashkenazi A, Bento C, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, et al. Polyglutamine tracts regulate beclin 1-dependent autophagy. Nature. 2017;545:108-111 pubmed publisher
  34. Xue M, Liu H, Zhang L, Chang H, Liu Y, Du S, et al. Computational identification of mutually exclusive transcriptional drivers dysregulating metastatic microRNAs in prostate cancer. Nat Commun. 2017;8:14917 pubmed publisher
  35. Youssef S, El Khateeb E, Aly D, Moussa M. Striae distensae: Immunohistochemical assessment of hormone receptors in multigravida and nulligravida. J Cosmet Dermatol. 2017;16:279-286 pubmed publisher
  36. Kumar A, Dumasia K, Deshpande S, Balasinor N. Direct regulation of genes involved in sperm release by estrogen and androgen through their receptors and coregulators. J Steroid Biochem Mol Biol. 2017;171:66-74 pubmed publisher
  37. Ibrahim M, Elwan W. Role of topical dehydroepiandrosterone in ameliorating isotretinoin-induced Meibomian gland dysfunction in adult male albino rat. Ann Anat. 2017;211:78-87 pubmed publisher
  38. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  39. Hashimoto Y, Shiina M, Kato T, Yamamura S, Tanaka Y, Majid S, et al. The role of miR-24 as a race related genetic factor in prostate cancer. Oncotarget. 2017;8:16581-16593 pubmed publisher
  40. Tse B, Volpert M, Ratther E, Stylianou N, Nouri M, McGowan K, et al. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. Oncogene. 2017;36:3417-3427 pubmed publisher
  41. Mu P, Zhang Z, Benelli M, Karthaus W, Hoover E, Chen C, et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science. 2017;355:84-88 pubmed publisher
  42. Shiina M, Hashimoto Y, Kato T, Yamamura S, Tanaka Y, Majid S, et al. Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians. Oncotarget. 2017;8:8356-8368 pubmed publisher
  43. Polanco M, Parodi S, Piol D, Stack C, Chivet M, Contestabile A, et al. Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy. Sci Transl Med. 2016;8:370ra181 pubmed publisher
  44. Abdelrazek H, Helmy S, Elsayed D, Ebaid H, Mohamed R. Ameliorating effects of green tea extract on cadmium induced reproductive injury in male Wistar rats with respect to androgen receptors and caspase- 3. Reprod Biol. 2016;16:300-308 pubmed publisher
  45. Tamura K, Kobayashi Y, Hirooka A, Takanami K, Oti T, Jogahara T, et al. Identification of the sexually dimorphic gastrin-releasing peptide system in the lumbosacral spinal cord that controls male reproductive function in the mouse and Asian house musk shrew (Suncus murinus). J Comp Neurol. 2017;525:1586-1598 pubmed publisher
  46. Loverro G, Resta L, Dellino M, Edoardo D, Cascarano M, Loverro M, et al. Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals. Taiwan J Obstet Gynecol. 2016;55:686-691 pubmed publisher
  47. Ho T, Huang J, Zhou N, Zhang Z, Koirala P, Zhou X, et al. Regulation of PCGEM1 by p54/nrb in prostate cancer. Sci Rep. 2016;6:34529 pubmed publisher
  48. Depaolo J, Wang Z, Guo J, Zhang G, Qian C, Zhang H, et al. Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis. Oncotarget. 2016;7:71417-71428 pubmed publisher
  49. Shen H, Zhao L, Feng X, Xu C, Li C, Niu Y. Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer. Oncotarget. 2016;7:60407-60418 pubmed publisher
  50. Lu H, Wang T, Li J, Fedele C, Liu Q, Zhang J, et al. αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor. Cancer Res. 2016;76:5163-74 pubmed publisher
  51. Liu Y, Wang K, Xing H, Zhai X, Wang L, Wang W. Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers. Oncol Lett. 2016;12:1240-1256 pubmed
  52. Xiao L, Feng Q, Zhang Z, Wang F, Lydon J, Ittmann M, et al. The essential role of GATA transcription factors in adult murine prostate. Oncotarget. 2016;7:47891-47903 pubmed publisher
  53. Hatem R, El Botty R, Chateau Joubert S, Servely J, Labiod D, de Plater L, et al. Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers. Oncotarget. 2016;7:48206-48219 pubmed publisher
  54. Dutta A, Le Magnen C, Mitrofanova A, Ouyang X, Califano A, Abate Shen C. Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation. Science. 2016;352:1576-80 pubmed publisher
  55. Bott L, Salomons F, Maric D, Liu Y, Merry D, Fischbeck K, et al. The polyglutamine-expanded androgen receptor responsible for spinal and bulbar muscular atrophy inhibits the APC/C(Cdh1) ubiquitin ligase complex. Sci Rep. 2016;6:27703 pubmed publisher
  56. Lu Y, Liu Y, Liao S, Tu W, Shen Y, Yan Y, et al. Epigenetic modifications promote the expression of the orphan nuclear receptor NR0B1 in human lung adenocarcinoma cells. Oncotarget. 2016;7:43162-43176 pubmed publisher
  57. Kim J, Yu J, Abdulkadir S, Chakravarti D. KAT8 Regulates Androgen Signaling in Prostate Cancer Cells. Mol Endocrinol. 2016;30:925-36 pubmed publisher
  58. Okato A, Goto Y, Kurozumi A, Kato M, Kojima S, Matsushita R, et al. Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer. Int J Oncol. 2016;49:111-22 pubmed publisher
  59. Kaushik A, Shojaie A, Panzitt K, Sonavane R, Venghatakrishnan H, Manikkam M, et al. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nat Commun. 2016;7:11612 pubmed publisher
  60. Mounir Z, Korn J, Westerling T, Lin F, Kirby C, Schirle M, et al. ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor. elife. 2016;5: pubmed publisher
  61. Feng Z, Wen H, Bi R, Ju X, Chen X, Yang W, et al. A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression. Sci Rep. 2016;6:25408 pubmed publisher
  62. Yard B, Adams D, Chie E, Tamayo P, Battaglia J, Gopal P, et al. A genetic basis for the variation in the vulnerability of cancer to DNA damage. Nat Commun. 2016;7:11428 pubmed publisher
  63. Zhu M, Bakhru P, Conley B, Nelson J, Free M, Martin A, et al. Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator. Nat Commun. 2016;7:11350 pubmed publisher
  64. Destouches D, Sader M, Terry S, Marchand C, Maillé P, Soyeux P, et al. Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer. Oncotarget. 2016;7:69397-69411 pubmed publisher
  65. Kumar P, Sharad S, Petrovics G, Mohamed A, Dobi A, Sreenath T, et al. Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1. Oncotarget. 2016;7:22791-806 pubmed publisher
  66. Olokpa E, Bolden A, Stewart L. The Androgen Receptor Regulates PPAR? Expression and Activity in Human Prostate Cancer Cells. J Cell Physiol. 2016;231:2664-72 pubmed publisher
  67. Johnson D, Hooker E, Luong R, Yu E, He Y, Gonzalgo M, et al. Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice. PLoS ONE. 2016;11:e0148851 pubmed publisher
  68. Varešlija D, McBryan J, Fagan A, Redmond A, Hao Y, Sims A, et al. Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors. Clin Cancer Res. 2016;22:2765-77 pubmed publisher
  69. Azakami D, Nakahira R, Kato Y, Michishita M, Onozawa E, Bonkobara M, et al. The canine prostate cancer cell line CHP-1 shows over-expression of the co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α. Vet Comp Oncol. 2017;15:557-562 pubmed publisher
  70. Shu S, Lin C, He H, Witwicki R, Tabassum D, Roberts J, et al. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature. 2016;529:413-417 pubmed publisher
  71. Mehraein Ghomi F, Church D, Schreiber C, Weichmann A, Basu H, Wilding G. Inhibitor of p52 NF-κB subunit and androgen receptor (AR) interaction reduces growth of human prostate cancer cells by abrogating nuclear translocation of p52 and phosphorylated AR(ser81). Genes Cancer. 2015;6:428-44 pubmed
  72. Hagberg Thulin M, Nilsson M, Thulin P, Céraline J, Ohlsson C, Damber J, et al. Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis. Mol Cell Endocrinol. 2016;422:182-191 pubmed publisher
  73. Seidel C, Schnekenburger M, Mazumder A, Teiten M, Kirsch G, Dicato M, et al. 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer. Biochem Pharmacol. 2016;99:31-52 pubmed publisher
  74. Munkley J, Livermore K, McClurg U, Kalna G, Knight B, McCullagh P, et al. The PI3K regulatory subunit gene PIK3R1 is under direct control of androgens and repressed in prostate cancer cells. Oncoscience. 2015;2:755-64 pubmed
  75. Pomerantz M, Li F, Takeda D, Lenci R, Chonkar A, Chabot M, et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nat Genet. 2015;47:1346-51 pubmed publisher
  76. Qiu M, Fan Q, Zhu Z, Kwan S, Chen L, Chen J, et al. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1. Oncotarget. 2015;6:31702-20 pubmed publisher
  77. Krakstad C, Tangen I, Hoivik E, Halle M, Berg A, Werner H, et al. ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma. Oncotarget. 2015;6:28440-52 pubmed publisher
  78. Adachi K, Miki Y, Saito R, Hata S, Yamauchi M, Mikami Y, et al. Intracrine steroid production and mammalian target of rapamycin pathways in pulmonary lymphangioleiomyomatosis. Hum Pathol. 2015;46:1685-93 pubmed publisher
  79. Fu Y, Cruz Monserrate Z, Helen Lin H, Chung Y, Ji B, Lin S, et al. Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype. Sci Rep. 2015;5:13347 pubmed publisher
  80. Mieritz M, Rakêt L, Hagen C, Nielsen J, Talman M, Petersen J, et al. A Longitudinal Study of Growth, Sex Steroids, and IGF-1 in Boys With Physiological Gynecomastia. J Clin Endocrinol Metab. 2015;100:3752-9 pubmed publisher
  81. Nilsen T, Thorsen L, Fosså S, Wiig M, Kirkegaard C, Skovlund E, et al. Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy. Scand J Med Sci Sports. 2016;26:1026-35 pubmed publisher
  82. Liu X, Chen X, Rycaj K, Chao H, Deng Q, Jeter C, et al. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. 2015;6:23959-86 pubmed
  83. Morris R, Purves Tyson T, Weickert C, Rothmond D, Lenroot R, Weickert T. Testosterone and reward prediction-errors in healthy men and men with schizophrenia. Schizophr Res. 2015;168:649-60 pubmed publisher
  84. Chen S, Okada M, Nakato R, Izumi K, Bando M, Shirahige K. The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin. J Biol Chem. 2015;290:21713-23 pubmed publisher
  85. Li X, Cui P, Jiang H, Guo Y, Pishdari B, Hu M, et al. Reversing the reduced level of endometrial GLUT4 expression in polycystic ovary syndrome: a mechanistic study of metformin action. Am J Transl Res. 2015;7:574-86 pubmed
  86. Khanna A, Rane J, Kivinummi K, Urbanucci A, Helenius M, Tolonen T, et al. CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations. Oncotarget. 2015;6:19661-70 pubmed
  87. Sun F, Indran I, Zhang Z, Tan M, Li Y, Lim Z, et al. A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants. Carcinogenesis. 2015;36:757-68 pubmed publisher
  88. Lee S, Luong R, Johnson D, Cunha G, Rivina L, Gonzalgo M, et al. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis. Oncogene. 2016;35:702-14 pubmed publisher
  89. Toropainen S, Malinen M, Kaikkonen S, Rytinki M, Jääskeläinen T, Sahu B, et al. SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin. Nucleic Acids Res. 2015;43:848-61 pubmed publisher
  90. Moser B, Schiefer A, Janik S, Marx A, Prosch H, Pohl W, et al. Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma. Am J Surg Pathol. 2015;39:541-8 pubmed publisher
  91. Tanaka S, Miki Y, Hashimoto C, Takagi K, Doe Z, Li B, et al. The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma. Mol Cell Endocrinol. 2015;401:56-64 pubmed publisher
  92. Kuo P, Huang C, Lee C, Chang H, Hsieh S, Chung Y, et al. BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability. Br J Cancer. 2015;112:391-402 pubmed publisher
  93. Cano L, Lavery D, Sin S, Spanjaard E, Brooke G, Tilman J, et al. The co-chaperone p23 promotes prostate cancer motility and metastasis. Mol Oncol. 2015;9:295-308 pubmed publisher
  94. Megas G, Chrisofos M, Anastasiou I, Tsitlidou A, Choreftaki T, Deliveliotis C. Estrogen receptor (α and β) but not androgen receptor expression is correlated with recurrence, progression and survival in post prostatectomy T3N0M0 locally advanced prostate cancer in an urban Greek population. Asian J Androl. 2015;17:98-105 pubmed publisher
  95. Kuroda N, Fujishima N, Hayes M, Moritani S, Ichihara S. Encapsulated papillary carcinoma, apocrine type, of the breast. Malays J Pathol. 2014;36:139-43 pubmed
  96. Valkenburg K, Yu X, De Marzo A, Spiering T, Matusik R, Williams B. Activation of Wnt/β-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia. Prostate. 2014;74:1506-20 pubmed publisher
  97. Thompson L, Bauer J, Chiosea S, McHugh J, Seethala R, Miettinen M, et al. Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature. Head Neck Pathol. 2015;9:181-95 pubmed publisher
  98. Wosnitzer M, Mielnik A, Dabaja A, Robinson B, Schlegel P, Paduch D. Ubiquitin Specific Protease 26 (USP26) expression analysis in human testicular and extragonadal tissues indicates diverse action of USP26 in cell differentiation and tumorigenesis. PLoS ONE. 2014;9:e98638 pubmed publisher
  99. Qiu M, Bao W, Wang J, Yang T, He X, Liao Y, et al. FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer. BMC Cancer. 2014;14:78 pubmed publisher
  100. Chen C, Brummet J, Lonstein J, Jordan C, Breedlove S. New knockout model confirms a role for androgen receptors in regulating anxiety-like behaviors and HPA response in mice. Horm Behav. 2014;65:211-8 pubmed publisher
  101. Samaan S, Tranchevent L, Dardenne E, Polay Espinoza M, Zonta E, Germann S, et al. The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways. Nucleic Acids Res. 2014;42:2197-207 pubmed publisher
  102. Lyu S, Yu Q, Ying G, Wang S, Wang Y, Zhang J, et al. Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer. Int J Oncol. 2014;44:229-37 pubmed publisher
  103. Kusafuka K, Onitsuka T, Muramatsu K, Miki T, Murai C, Suda T, et al. Salivary duct carcinoma with rhabdoid features: report of 2 cases with immunohistochemical and ultrastructural analyses. Head Neck. 2014;36:E28-35 pubmed publisher
  104. Ni M, Chen Y, Fei T, Li D, Lim E, Liu X, et al. Amplitude modulation of androgen signaling by c-MYC. Genes Dev. 2013;27:734-48 pubmed publisher
  105. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  106. Sarkar S, Brautigan D, Parsons S, Larner J. Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells. Oncogene. 2014;33:26-33 pubmed publisher
  107. Lei K, Chen L, Georgiou E, Sooranna S, Khanjani S, Brosens J, et al. Progesterone acts via the nuclear glucocorticoid receptor to suppress IL-1?-induced COX-2 expression in human term myometrial cells. PLoS ONE. 2012;7:e50167 pubmed publisher
  108. Coffey K, Blackburn T, Cook S, Golding B, Griffin R, Hardcastle I, et al. Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer. PLoS ONE. 2012;7:e45539 pubmed publisher
  109. Hsu F, Yang M, Lin E, Tseng C, Lin H. The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells. Am J Physiol Endocrinol Metab. 2011;300:E902-8 pubmed publisher
  110. Asioli S, Marucci G, Ficarra G, Stephens M, Foschini M, Ellis I, et al. Polymorphous adenocarcinoma of the breast. Report of three cases. Virchows Arch. 2006;448:29-34 pubmed